BeStock  
Stocks › Biotechnology › ZYME

Zymeworks ZYME

US equityMarket cap rank #2745Biotechnology
$26.14 −$0.72 (-2.68%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.14 0.00%
Open$26.30
Prev close$26.86
Day range$26.09 – $27.57
Volume738.8K
Market cap$1.81B
P/E (TTM)49.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings49.5x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average -6.8x

#2576 of 2993 stocks by PE (1 = cheapest)

Price / book7.0x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average 4.0x

#4717 of 5330 stocks by PB (1 = cheapest)

Price / sales6.8x
CheapRich

Below its usual level · 20th percentile, 5-year average 14.1x

#4240 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-39x-4x32x67xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$28.53
Price vs. fair value-8.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.01 – 4.01 87% (pricier than usual) #4717 of 5330 (1 = cheapest)
PE 49.51 33.53 -6.84 100% (pricier than usual) #2576 of 2993 (1 = cheapest)
PS 6.81 5.08 14.09 20% (cheaper than usual) #4240 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ZYME.

Sign in to join the discussion.

Scroll to Top